J A Mailliard

8.7k citations

60 papers · 6.7k indexed · 2 hit papers · h-index 35

Impact in

Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Colorectal Cancer Screening and Detection
Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer

Papers in

Oncology 41
- Colorectal Cancer Treatments and Studies 17
- Cancer Treatment and Pharmacology 15
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 5
Pulmonary and Respiratory Medicine 18
- Lung Cancer Treatments and Mutations 8

Co-authors: James E. Krook Harry S. Wieand Michael A. Poon C G Moertel M. J. OʼConnell Loren K. Tschetter Charles L. Loprinzi Stephen A. Cullinan
Journals: Journal of Clinical Oncology (38 papers)Annals of Oncology (4 papers)JNCI Journal of the National Cancer Institute (2 papers)Leukemia (1 paper)Gynecologic Oncology (1 paper)
Partner nations: United States Canada Netherlands

In The Last Decade

J A Mailliard

59 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma 1991 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1991 New England Journal of Medicine
1989 Journal of Clinical Oncology

Peers

Countries citing papers authored by J A Mailliard

Since Specialization

Citations

This map shows the geographic impact of J A Mailliard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Mailliard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Mailliard more than expected).

Fields of papers citing papers by J A Mailliard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Mailliard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Mailliard. The network helps show where J A Mailliard may publish in the future.

Co-authors

The 25 scholars most cited alongside J A Mailliard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J A Mailliard Line = papers co-authored together J A Mailliard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group Annals of Oncology ·Tang Wei, Aminah Jatoi, Philip J. Stella, Nathan R. Foster, Loren K. Tschetter, Steven R. Alberts, Shaker R. Dakhil, J A Mailliard, Patrick J. Flynn, Daniel A. Nikcevich	2006	42
2	Investigating four ‘myths’ surrounding dysphagia in patients with metastatic esophageal cancer. a multi-institutional study from the North Central Cancer Treatment Group* Diseases of the Esophagus ·Aminah Jatoi, Nathan R. Foster, Patricia Johnson, George G. Klee, J. Fernando Quevedo, Roscoe F. Morton, Suresh Nair, Carl G. Kardinal, J A Mailliard	2004	7
3	Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting Nicotine & Tobacco Research ·Gary A. Croghan, Jeff A. Sloan, Ivana T. Croghan, Paul Novotny, R. Douglas Hurt, 敬峰瑞, June Dahl, J A Mailliard, Larry P. Ebbert, Re DeA o, June Dahl, Martin Wiesenfeld, Ralph Levitt, Philip J. Stella, Patricia Johnson, Loren K. Tschetter, Charles L. Loprinzi	2003	49
4	Determination of hemoglobin levels in the finger using near infrared spectroscopy Clinical & Laboratory Haematology ·Marc Rendell, Elizabeth A. Anderson, Kunqin Cheng, J A Mailliard, D. E. Honigs, Robert Rosenthal	2003	27
5	A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia Leukemia ·Ayalew Tefferi, Chung‐Yi Li, T. Gamero, Fuso Zhang, Cristine Allmer, Ralph Levitt, J C Michalak, Yuehui Zhou, George Enow Orock, TE Witzig, E. Moroni, J A Mailliard	2001	10
6	Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. Journal of Clinical Oncology ·Henry C. Pitot, Donald B. Wender, Matthew J. O’Connell, Georgene Schroeder, Richard M. Goldberg, Joseph Rubin, J A Mailliard, James A. Knost, C Ghosh, Anna Torres Lacomba, Ralph Levitt, Harold E. Windschitl	1997	220
7	Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. Journal of Clinical Oncology ·M. J. OʼConnell, J A Mailliard, Michael Kahn, J. S. Macdonald, Daniel G. Haller, Robert J. Mayer, Harry S. Wieand	1997	447
8	Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. Journal of Clinical Oncology ·Thomas E. Witzig, Louis Letendre, James B. Gerstner, Georgene Schroeder, J A Mailliard, Gerardo Colón‐Otero, Robert F. Marschke, Harold E. Windschitl	1995	33
9	Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. Journal of Clinical Oncology ·D F Hayes, J. A. Van Zyl, A Hacking, L. Goedhals, W. R. Bezwoda, J A Mailliard, SE Jones, Charles L. Vogel, Robert F. Berris, Irving Shemano	1995	180
10	Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. Journal of Clinical Oncology ·James R. Jett, Andrew W. Maksymiuk, John Q. Su, J A Mailliard, James E. Krook, Loren K. Tschetter, Carl G. Kardinal, Donald I. Twito, Ralph Levitt, James B. Gerstner	1994	95
11	Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. Journal of Clinical Oncology ·Charles L. Loprinzi, Richard M. Goldberg, John Q. Su, J A Mailliard, Steven A. Kuross, Andrew W. Maksymiuk, J. W. Kugler, James R. Jett, C Ghosh, Masahiro Sawada	1994	78
12	Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. Journal of Clinical Oncology ·Stephen A. Cullinan, C G Moertel, Harry S. Wieand, M J O'Connell, Michael A. Poon, James E. Krook, J A Mailliard, Loren K. Tschetter	1994	114
13	Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. Journal of Clinical Oncology ·Andrew W. Maksymiuk, James R. Jett, John D. Earle, 陈必坤, Walter L. Bonam, J A Mailliard, Carl G. Kardinal, James E. Krook, M H Veeder, Martin Wiesenfeld	1994	53
14	Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. Journal of Clinical Oncology ·C G Moertel, Leonard L. Gunderson, J A Mailliard, Patrick McKenna, James A. Martenson, Patrick A. Burch, Nitish Pal	1994	61
15	Pilot Study of Accelerated Hyperfractionated Thoracic Radiation Therapy Plus Concomitant Etoposide and Cisplatin Chemotherapy in Patients With Unresectable Stage III Non-Small-Cell Carcinoma of the Lung JNCI Journal of the National Cancer Institute ·Edward G. Shaw, William L. McGinnis, James R. Jett, 陈必坤, A R Frank, J A Mailliard, Eduard Borisovich Yagubskii, Jose Myriam Saint-Fleur, Frank Fosu Mensah	1993	42
16	Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. Journal of Clinical Oncology ·James R. Jett, Lloyd K. Everson, Terry M. Therneau, James E. Krook, Robert J. Dalton, Robert F. Marschke, M H Veeder, S. Fred Brunk, J A Mailliard, Donald I. Twito	1990	47
17	Randomized Trial of Doxorubicin Alone or Combined with Vincristine and Mitomycin C in Women with Metastatic Breast Cancer American Journal of Clinical Oncology ·James N. Ingle, J A Mailliard, Daniel J. Schaid, James E. Krook, James B. Gerstner, Masahiro Sawada, Robert F. Marschke, Hui Long, G McCormack, John Foley	1989	14
18	Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer. Journal of Clinical Oncology ·James N. Ingle, Donald I. Twito, Daniel J. Schaid, Stephen A. Cullinan, James E. Krook, J A Mailliard, Robert F. Marschke, Harry J. Long, Yongfeng HE, Harold E. Windschitl	1988	23
19	Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma Gynecologic Oncology ·J H Edmonson, James E. Krook, B V Sanford, George D. Malkasian, Lloyd K. Everson, John A. Jefferies, J A Mailliard	1987	40
20	Carcinoid disease of the tricuspid valve: Case report William Ross, Syed M. Mohiuddin, J A Mailliard, Dez Hughes	1982	1

About J A Mailliard

J A Mailliard is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Pathology and Forensic Medicine and Genetics, having authored 60 papers that have together received 6.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), Cancer Treatment and Pharmacology (15 papers), Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Treatments and Mutations (8 papers), Estrogen and related hormone effects (7 papers), Cancer therapeutics and mechanisms (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (4.6k citations), Pathology and Forensic Medicine (1.1k citations), Pulmonary and Respiratory Medicine (1.9k citations), Hepatology (432 citations) and Surgery (1.9k citations). J A Mailliard has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include James E. Krook, Harry S. Wieand, Michael A. Poon, C G Moertel, M. J. OʼConnell, Loren K. Tschetter, Charles L. Loprinzi, Stephen A. Cullinan, Leonard L. Gunderson and Lloyd K. Everson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JNCI Journal of the National Cancer Institute, Leukemia and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact